Vivoryon Therapeutics N.V.

VVY.AS · AMS
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Assets
Cash & Equivalents€4,837€9,365€15,272€18,562
Short-Term Investments€0€0€0€10,000
Receivables€0€312€333€495
Inventory€0€0€0€0
Other Curr. Assets€407€390€442€755
Total Curr. Assets€5,244€10,067€16,047€29,812
Property Plant & Equip (Net)€89€124€40€76
Goodwill€0€0€0€0
Intangibles€831€865€904€941
Long-Term Investments€0€0€0€0
Tax Assets€0€0€0€0
Other NC Assets€255€228€0€0
Total NC Assets€1,175€1,217€944€1,017
Other Assets€0€0€0€0
Total Assets€6,419€11,284€16,991€30,829
Liabilities
Payables€1,025€1,015€1,465€2,894
Short-Term Debt€122€120€20€76
Tax Payable€0€0€69€10
Deferred Revenue€0€0€0€0
Other Curr. Liab.€152€264€158€202
Total Curr. Liab.€1,299€1,399€1,712€3,182
LT Debt€11€42€0€0
Deferred Rev, NC€0€0€0€0
Deferred Tax Liab, NC€0€0€0€0
Other NC Liab.€1,928€1,963€1,299€1,365
Total NC Liab.€1,939€2,005€1,299€1,365
Other Liabilities€0€0€0€0
Cap. Leases€72€102€10€38
Total Liabilities€3,238€3,404€3,011€4,547
Equity
Pref Stock€0€0€0€0
Common Stock€262€261€26,067€26,067
Retained Earnings-€174,840-€169,367-€162,358-€148,799
AOCI€16,282-€268€14,600-€256
Other Equity€161,477€177,254€135,671€149,270
Total Equity€3,181€7,880€13,980€26,282
Supplemental Information
Minority Interest€0€0€0€0
Total Liab. & Tot. Equity€6,419€11,284€16,991€30,829
Net Debt-€4,704-€9,203-€15,252-€18,486